MedTrace Logo

The Effect and Mechanism of MMP-9 in Inducing Atherosclerosis

NCT04424706 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2020-06-11

No results posted yet for this study

Summary

The study will assess the serum expression of MMP-9 in normal people, type 2 diabetic patients and type 2 diabetic patients with atherosclerosis.

Conditions

Interventions

DIAGNOSTIC_TEST

diagnosed as type 2 diabetes without atherosclerosis

patients diagnosed as type 2 diabetes without atherosclerosis

DIAGNOSTIC_TEST

diagnosed as type 2 diabetes with atherosclerosis

patients diagnosed as type 2 diabetes with atherosclerosis

DIAGNOSTIC_TEST

people without type 2 diabetes or atherosclerosis

normal people without type 2 diabetes or atherosclerosis

Sponsors & Collaborators

  • Majianhua

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2020-11-30
Completion
2020-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04424706 on ClinicalTrials.gov